Authors:
NORTHFELT DW
DEZUBE BJ
THOMMES JA
MILLER BJ
FISCHL MA
FRIEDMANKIEN A
KAPLAN LD
DUMOND C
MAMELOK RD
HENRY DH
Citation: Dw. Northfelt et al., PEGYLATED-LIPOSOMAL DOXORUBICIN VERSUS DOXORUBICIN, BLEOMYCIN, AND VINCRISTINE IN THE TREATMENT OF AIDS-RELATED KAPOSIS-SARCOMA - RESULTS OF A RANDOMIZED PHASE-III CLINICAL-TRIAL, Journal of clinical oncology, 16(7), 1998, pp. 2445-2451
Authors:
SPARANO JA
HU XP
WIERNIK PH
SARTA C
REDDY DM
HANAU L
HENRY DH
Citation: Ja. Sparano et al., OPPORTUNISTIC INFECTION AND IMMUNOLOGICAL FUNCTION IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS - ASSOCIATED NON-HODGKINS-LYMPHOMA TREATEDWITH CHEMOTHERAPY, Journal of the National Cancer Institute, 89(4), 1997, pp. 301-307
Authors:
ESTRIN JT
FORD PA
HENRY DH
STRADDEN AP
MASON BA
Citation: Jt. Estrin et al., ERYTHROPOIETIN PERMITS HIGH-DOSE CHEMOTHERAPY WITH PERIPHERAL-BLOOD STEM-CELL TRANSPLANT FOR A JEHOVAH-WITNESS, American journal of hematology, 55(1), 1997, pp. 51-52
Authors:
SPARANO JA
WIERNIK PH
HU XP
SARTA C
SCHWARTZ EL
SOEIRO R
HENRY DH
MASON B
RATECH H
DUTCHER JP
Citation: Ja. Sparano et al., PILOT TRIAL OF INFUSIONAL CYCLOPHOSPHAMIDE, DOXORUBICIN, AND ETOPOSIDE PLUS DIDANOSINE AND FILGRASTIM IN PATIENTS WITH HUMAN IMMUNODEFICIENCY VIRUS-ASSOCIATED NON-HODGKINS-LYMPHOMA, Journal of clinical oncology, 14(11), 1996, pp. 3026-3035
Citation: Dh. Henry et N. Thatcher, PATIENT SELECTION AND PREDICTING RESPONSE TO RECOMBINANT-HUMAN-ERYTHROPOIETIN IN ANEMIC CANCER-PATIENTS, Seminars in hematology, 33(1), 1996, pp. 2-5
Citation: Dh. Henry et R. Abels, BENEFITS OF EPOETIN ALFA THERAPY IN ANEMIC CANCER-PATIENTS RECEIVING CHEMOTHERAPY, Journal of clinical oncology, 13(9), 1995, pp. 2473-2474
Authors:
REVICKI DA
BROWN RE
HENRY DH
MCNEILL MV
RIOS A
WATSON T
Citation: Da. Revicki et al., RECOMBINANT-HUMAN-ERYTHROPOIETIN AND HEALTH-RELATED QUALITY-OF-LIFE OF AIDS PATIENTS WITH ANEMIA, Journal of acquired immune deficiency syndromes, 7(5), 1994, pp. 474-484
Citation: Dh. Henry, CLINICAL-APPLICATION OF RECOMBINANT ERYTHROPOIETIN IN ANEMIC CANCER-PATIENTS, Hematology/oncology clinics of North America, 8(5), 1994, pp. 961
Citation: Dh. Henry et Ri. Abels, RECOMBINANT-HUMAN-ERYTHROPOIETIN IN THE TREATMENT OF CANCER AND CHEMOTHERAPY-INDUCED ANEMIA - RESULTS OF DOUBLE-BLIND AND OPEN-LABEL FOLLOW-UP-STUDIES, Seminars in oncology, 21(2), 1994, pp. 21-28
Authors:
ADAMSON JW
SPIVAK JL
KLEIN HG
HENRY DH
DENTON T
SILVER RT
Citation: Jw. Adamson et al., NEW APPROACHES TO THE TREATMENT OF CANCER-RELATED ANEMIA - A PANEL DISCUSSION, Seminars in oncology, 21(2), 1994, pp. 36-41
Authors:
CASE DC
BUKOWSKI RM
CAREY RW
FISHKIN EH
HENRY DH
JACOBSON RJ
JONES SE
KELLER AM
KUGLER JW
NICHOLS CR
SALMON SE
SILVER RT
STORNIOLO AM
WAMPLER GL
DOOLEY CM
LARHOLT KM
NELSON RA
ABELS RI
Citation: Dc. Case et al., RECOMBINANT-HUMAN-ERYTHROPOIETIN THERAPY FOR ANEMIC CANCER-PATIENTS ON COMBINATION CHEMOTHERAPY, Journal of the National Cancer Institute, 85(10), 1993, pp. 801-806
Citation: Dh. Henry, RECOMBINANT-HUMAN-ERYTHROPOIETIN FOR THE TREATMENT OF ANEMIA IN PATIENTS WITH ADVANCED CANCER, Seminars in hematology, 30(4), 1993, pp. 12-16
Citation: Ri. Abels et Dh. Henry, PREDICTING RESPONSE TO RECOMBINANT-HUMAN-ERYTHROPOIETIN - RESPONSE, Annals of internal medicine, 119(1), 1993, pp. 91-92
Authors:
FISCHL MA
OLSON RM
FOLLANSBEE SE
LALEZARI JP
HENRY DH
FRAME PT
REMICK SC
SALGO MP
LIN AH
NAUSSKAROL C
LIEBERMAN J
SOO WJ
Citation: Ma. Fischl et al., ZALCITABINE COMPARED WITH ZIDOVUDINE IN PATIENTS WITH ADVANCED HIV-1 INFECTION WHO RECEIVED PREVIOUS ZIDOVUDINE THERAPY, Annals of internal medicine, 118(10), 1993, pp. 762-769